Josep Gomez-Lara1,2,3*, MD, PhD; Luis Teruel1,2,3, MD; Silvia Homs1,2,3, MD; José Luis Ferreiro1,2,3, MD; Rafael Romaguera1,2,3, MD; Gerard Roura1,2,3, MD; Guillermo Sánchez-Elvira1,2,3, MD; Francesc Jara1,2,3, MD; Salvatore Brugaletta4, MD, PhD; Joan-Antoni Gomez-Hospital1,2,3, MD, PhD; Angel Cequier1,2,3, MD, PhD
1. Department of Interventional Cardiology, Heart Disease Institute, Hospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain; 2. Institut d’Investigacio Biomedica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain;
Aims: Chronic total occlusions (CTO) are the final stage of atherosclerosis. Occluded coronary arteries have large plaque burden and negative re